Laboratoires Euromedis specializes in the design, manufacturing and distribution of medical equipment intended primarily for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The products include gloves (No. 1 in France in disposable medical gloves), surgical items (sensors, pockets, scalpels, etc.), hygiene and protection equipment (white-coats, masks, shoes, etc.), parenteral approaches (needles, syringes, transfusion equipment, etc.), diagnostic products, etc.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	14.28M 16.46M 13.29M 12.21M 23.07M 1.57B 23.43M 157M 61.51M 782M 61.79M 60.44M 2.59B	P/E 2024	-2.05x	P/E 2025	-84.9x
Enterprise Value	3.71M 4.28M 3.45M 3.17M 6M 408M 6.09M 40.72M 15.99M 203M 16.06M 15.71M 674M	EV / Sales 2024	0.57x	EV / Sales 2025	0.01x
Free-Float	34.87%	Yield 2024 *	-	Yield 2025	-

04-29	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
31/10/25	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
04/05/25	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24/10/24	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2024	CI
31/10/23	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2023	CI
27/04/23	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2022	CI
30/09/22	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2022	CI
29/04/22	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2021	CI
30/09/21	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2021	CI
08/07/21	Euromedis Groupe : Malaysia rubber glove body pleads for go-ahead to restart factories	RE
26/04/21	Global markets live: Philips, Crédit Suisse, Nestlé...
23/04/21	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2020	CI
23/09/20	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2020	CI

31/10/25	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER SEMESTRIEL 2025	PU
31/10/25	Laboratoires Euromedis : Euromedis - Communiqué semestriel 2025	PU
10/12/24	LABORATOIRES EUROMEDIS : Ajustement du contrat de liquidité	PU
26/04/24	Laboratoires Euromedis : Euromedis - Communiqué résultat 2023	PU
29/09/22	EUROMEDIS : Rapport Financier semestriel 2022	PU

06-19	Agenda des dividendes et des AG de la semaine : session dividendes pour la galaxie Bolloré
05-06	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER ANNUEL 2025
05-06	LABORATOIRES EUROMEDIS : Fin du contrat de liquidité
04-24	Laboratoires Euromedis : Communiqué résultat 2025
04-24	Laboratoires Euromedis : Résultats 2025 (7. Laboratoires Euromedis Communiqu e de presse r sultat 2025 v23.04.26)

Director	Title	Age	Since
Mathieu Roturier CHM	Chairman	49	25/11/2019
Joseph Asselin BRD	Director/Board Member	52	07/03/2017
Marion Tramier BRD	Director/Board Member	40	07/03/2017

EUROMEDIS Share Price Swiss Exchange

Stocks

OXEUMD

FR0000075343

Medical Equipment, Supplies & Distribution

Valuation: EUROMEDIS

Latest news : EUROMEDIS

Press Releases: EUROMEDIS

News in other languages: EUROMEDIS

Managers and Directors: EUROMEDIS

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EUROMEDIS	-.--%	-.--%	-	-	17.26M
ABBOTT LABORATORIES	+0.09%	+4.91%	-17.78%	-6.24%	183B
MEDTRONIC PLC	-0.37%	+4.12%	-6.82%	-3.24%	110B
CENCORA, INC.	-0.29%	+2.06%	+6.70%	+66.88%	60.75B
HOYA CORPORATION	+3.50%	-0.66%	+30.35%	+55.04%	50.01B
BECTON, DICKINSON AND COMPANY	+0.10%	+8.27%	-8.77%	-40.92%	45.59B
MEDLINE INC.	+0.41%	+4.38%	-	-	33.08B
DEXCOM, INC.	+11.95%	+18.40%	-6.30%	-36.96%	28.76B
WEST PHARMACEUTICAL SERVICES, INC.	+0.40%	-4.08%	+36.82%	-6.70%	23.9B
STERIS PLC	-1.22%	+8.43%	-0.38%	-0.71%	22.53B
Average	+1.45%	+4.36%	+4.23%	+3.39%	61.9B
Weighted average by Cap.	+0.82%	+5.48%	-3.40%	+4.23%

	2024	2025
Net sales	36.41M 41.97M 33.88M 31.13M 58.83M 4B 59.75M 399M 157M 1.99B 158M 154M 6.61B	41.06M 47.34M 38.21M 35.11M 66.34M 4.52B 67.38M 450M 177M 2.25B 178M 174M 7.45B
Net income	-6.11M -7.04M -5.68M -5.22M -9.87M -672M -10.02M -67M -26.32M -335M -26.44M -25.86M -1.11B	-132K -152K -123K -113K -213K -14.49M -216K -1.45M -568K -7.22M -570K -558K -23.92M
Net Debt	8.04M 9.26M 7.48M 6.87M 12.98M 884M 13.19M 88.16M 34.63M 440M 34.78M 34.02M 1.46B	-10.57M -12.18M -9.83M -9.03M -17.07M -1.16B -17.34M -116M -45.52M -579M -45.73M -44.73M -1.92B